ET
AUPH icon

Entropy Technologies’s Aurinia Pharmaceuticals AUPH Stock Holding History

Entropy Technologies’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,855
Closed -$531K – 954
2026
Q1 		$531K Sell
35,855
-11,842
-25% -$173K 0.02% 574
2025
Q4 		$761K Buy
47,697
+29,338
+160% +$416K 0.04% 454
2025
Q3 		$203K Buy
+18,359
New +$201K 0.02% 753

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Entropy Technologies's AUPH Position: Q2 2026 in Review

Entropy Technologies sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2026, closing a stake of 35,855 shares — an estimated $531K sold.

Entropy Technologies first reported a position in AUPH in Q3 2025 and held it in 3 quarters. The position peaked at $761K in Q4 2025. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Entropy Technologies reported no remaining Aurinia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Entropy Technologies sold 35,855 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $531K.
  • Entropy Technologies first reported a position in Aurinia Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • Entropy Technologies's Aurinia Pharmaceuticals position peaked at $761K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.